Enhancement of solubility and dissolution of glipizide by solid dispersion (kneading) technique

D Choudhary, S Kumar, G D gupta

Abstract


Glipizide is a poorly water-soluble (BCS class II) antidiabetic drug. Due to the poor water solubility of this drug, its bioavailability is dissolution rate-limited. The purpose of this study was is to increase the solubility of Glipizide (GZ)
in aqueous media by solid dispersion (SDs) technique with Poloxamer (PXM) 188 and Poloxamer (PXM) 407 by using the kneading method.The GZ-PXM solid dispersion system was characterized by dDifferential scanning calorimetry (DSC), X-ray powder diffraction (XRD) analysis, Fourier transform-infrared spectroscopy (FT-IR) and Scanning electron microscopy (SEM), and in vitro dissolution studies. No chemical interaction was found between GZ and PXM 188 or PXM 407. The results from DSC, XRD and SEM studies show that PXM 188 or PXM 407 inhibits the crystallization of GZ. The SDs prepared in this study were found to have better dissolution rates in comparisoncompared to intact GZ and physical mixture of PXM 188 or PXM 407 and GZ. It was found that the optimum weight ratio for drug: Carrier is 1:5 for PXM 188 and 1:6 for PXM 407.


Full Text:

PDF

References


Serajuddin AT. Solid dispersion of poorly water soluble drugs: Early

promises, subsequent problems and recent breakthrough. J Pharm Sci

;88:1058-66.

Lobenberg R, Amidon GL. Modern bioavailability bioequivalence and

biopharmaceutics classification system: New scientific approaches to

international regulatory standards. Eur J Pharm Biopharm 2000;50:3-12.

Sharma DK, Joshi SB. Solubility enhancement strategies for poorly

water soluble drugs in solid dispersion: A Review. Asian J Pharm

;1:9-19.

Pouton CW. Formulation of poorly water-soluble drugs for oral

administration: Physicochemical and physiological issues and the lipid

formulation classification systems. Eur J Pharm Sci 2006;29:278-87.

Leuner C, Dressman J. Improving drug solubility for oral delivery using

solid dispersion. Eur J Pharm Biopharm 2000;50:47-60.

Vasconceleos T, Sarmento B, Costa P. Solid dispersion as strategy to

improve oral bioavailability of poor water soluble drugs. Drug Discovery

Today 2007;12:1068-75.

Craig DQ. The mechanism of drug release from solid dispersions in

water-soluble polymers. Int J Pharm 2002;231:131-44.

Chiou WL, Riegelman S. Pharmaceutical applications of solid dispersion

systems. J Pharm Sci 1971;60:1281-302.

Aly AM, Qato MK, Ahmad MO. Enhancement of the dissolution rate

and bioavailability of glipizide through cyclodextrin inclusion complex.

Pharma Tech 2003;7:54-62.

Mehramizi A, Alijani B Pourfarzib M. Solid carriers for improved

solubility of glipizide in osmotically controlled oral drug delivery

system. Drug Dev Ind Pharm 2007;33:812-23.

Himasankar K, Babu GV, Babu PS, Prasad CD, Rao LN Murthy KV.

Studies on the solid dispersion systems of glipizide. Indian J Pharm

Sci 2002;64:433-9.

Modi A, Tayade P. Enhancement of dissolution profile by solid dispersion

(kneading) technique. AAPS PharmsciTech 2006;7:68.

Kalaiselvan R, Mohanta GP, Manna PK, Manavalan R. Studies on

machenism of enhanced dissolution of albendazole solid dispersion

with crystalline carriers. Indian J Pharm Sci 2006;68:599-607.

Rao MV, Shyam T, Appa RB, Srinivasa RY. Formulation and characterization

of meloxicam solid dispersions. The Indian Pharmacist 2008;70:67-70.

Higuchi T, Connors KA. Phase solubility techniques. Adv Anal Chem

Instr 1965;4:117-212.

Khan KA. The concept of dissolution efficiency. J Pharm Phamacol

;27:48-9.




DOI: http://dx.doi.org/10.22377/ajp.v3i3.274

Refbacks

  • There are currently no refbacks.